Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter to Evaluate Eksigent s Microfluidics Technology

NEW YORK, July 20 – Eksigent Technologies said Friday it had signed a deal with Beckman Coulter to jointly look for ways to incorporate Eksigent’s microfluidics technology into Beckman Coulter’s instruments.

Financial terms of the deal were not disclosed.

Established in May of last year, Eksigent of Livermore, Calif., has developed lab-on-a-chip technology, including pumps, valves, and microfabricated systems. The basis of the technology is the electrokinetic pump, which uses an applied electric field to generate fluid flow and high pressures. 

The company said that its pump can be applied to combinatorial chemistry, sample preparation, heat transfer, microvalving, and actuation.

“We anticipate that Eksigent's technology will enable the development of new instrumentation platforms that provide significant advantages to Beckman Coulter's customers,” Jim Osborne, vice president of Advanced Technology at Beckman Coulter, said in a statement.

Beckman Coulter of Fullerton, Calif., develops instruments and products that help to automate simplify laboratory processes. The company also develops diagnostics.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more